← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XGEN PHARMS · Approved 2001-08-17

Drug application

FDA Application #

ANDA065013

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN SULFATE

Generic name

TOBRAMYCIN

Active ingredients

TOBRAMYCIN SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

XGEN PHARMS

Manufacturer

XGen Pharmaceuticals DJB, Inc.

First approval

2001-08-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown